Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Grants
$350k
2 grants · CORDIS
Backers
1
Sofinnova Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 1, 2024 Won a grant $156k · CORDIS Sep 1, 2023 Won a grant $195k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Jan 2024 $156k — CORDIS
Grant Sep 2023 $195k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
Mammoth Biosciences201-500 employees • 1 role
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Cell MicrosystemsVenture round $6.5M · 3 yr ago • Founded 2021 • 51-200 employees
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the…
GenSight BiologicsVenture round $1.8M · 6 mo ago • 201-500 employees
On this page Key figures Home > Who we are > Company Our mission is to turn scientific advances in gene therapy into novel treatments for…
Jaguar Gene TherapySeries B $139M · 5 yr ago • 201-500 employees
At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…
Bright Peak TherapeuticsSeries C $90M · 2 yr ago • Founded 2012
Creating next generation immunotherapy treatments for cancer and autoimmune disease.

Overview

Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.

Financials

Total raised
$350k
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2024 $156k Details
Grant 2023 $195k Details